ResearcherTriemli HospitalActive in the last 2 years

Markus Weber

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8203-0382; OpenAlex author ID A5026110715. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Effect of volatile versus total intravenous anaesthesia on circulating tumour cells after pancreatic adenocarcinoma resection: multicentre randomized clinical … Co-author DOI 10.1093/bjs/znad357 ↗
Chemoradiotherapy after curative surgery for locally advanced pancreatic cancer: A 20-year single center experience. Last author DOI 10.1016/j.suronc.2020.11.012 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Beatrice Beck‐Schimmer · 1 shared paper, 2024 · strength 0.21
- Paper Effect of volatile versus total intravenous anaesthesia on circulating tumour cells after pancreatic adenocarcinoma res… DOI 10.1093/bjs/znad357 ↗
Martin Schläpfer · 1 shared paper, 2024 · strength 0.21
- Paper Effect of volatile versus total intravenous anaesthesia on circulating tumour cells after pancreatic adenocarcinoma res… DOI 10.1093/bjs/znad357 ↗
Pascal Weibel · 1 shared paper, 2021 · strength 0.17
- Paper Chemoradiotherapy after curative surgery for locally advanced pancreatic cancer: A 20-year single center experience. DOI 10.1016/j.suronc.2020.11.012 ↗
Matea Pavic · 1 shared paper, 2021 · strength 0.17
- Paper Chemoradiotherapy after curative surgery for locally advanced pancreatic cancer: A 20-year single center experience. DOI 10.1016/j.suronc.2020.11.012 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.